Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -43.31% is 14% above its 5-year average of -50.33%, around the middle of its 5-year range (-78.04%–-14.15%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.41% below its 12-month average of -41.88%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -43.31%.
RETURN ON INVESTED CAPITAL (ROIC)
-43.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-41.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-54.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-50.33%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-51.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-72.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-90.96%
CURRENT VS TTM AVG
-3.41%
CURRENT VS 3Y AVG
+20.69%
CURRENT VS 5Y AVG
+13.94%
CURRENT VS 10Y AVG
+16.37%
CURRENT VS 15Y AVG
+40.61%
CURRENT VS 20Y AVG
+52.39%
SECTOR MEDIAN · HEALTHCARE
-28.79%
median of 492 covered companies
CURRENT VS SECTOR MEDIAN
-50.46%
vs the sector median at left
Cytosorbents Corporation
Market Cap
$12.46M
Return on Invested Capital (ROIC)
-43.31%
TTM Avg
-41.88%
3Y Avg
-54.61%
5Y Avg
-50.33%
Market Cap
$12.63M
Return on Invested Capital (ROIC)
-203.50%
TTM Avg
-154.20%
3Y Avg
-205.70%
5Y Avg
-169.89%
Market Cap
$11.95M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-47.37%
3Y Avg
-38.90%
5Y Avg
-35.62%
Market Cap
$11.94M
Return on Invested Capital (ROIC)
-19.53%
TTM Avg
-16.13%
3Y Avg
-40.26%
5Y Avg
-33.39%
Market Cap
$13.34M
Return on Invested Capital (ROIC)
-74.94%
TTM Avg
-273.26%
3Y Avg
-277.38%
5Y Avg
-186.51%
Market Cap
$11.42M
Return on Invested Capital (ROIC)
-240.64%
TTM Avg
-174.03%
3Y Avg
-198.05%
5Y Avg
-242.53%
Market Cap
$11.41M
Return on Invested Capital (ROIC)
-32.27%
TTM Avg
-112.80%
3Y Avg
-113.13%
5Y Avg
-94.20%
Market Cap
$13.55M
Return on Invested Capital (ROIC)
-57.53%
TTM Avg
-660.45%
3Y Avg
-553.22%
5Y Avg
-396.73%
Market Cap
$13.62M
Return on Invested Capital (ROIC)
-91.74%
TTM Avg
-119.31%
3Y Avg
-112.64%
5Y Avg
-88.90%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytosorbents Corporation (CTSO) | $12.46M | -43.31% | -41.88% | -54.61% | -50.33% |
| Dare Bioscience, Inc. (DARE)vs › | $12.63M | -203.50% | -154.20% | -205.70% | -169.89% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.95M | N/A | -47.37% | -38.90% | -35.62% |
| IRIDEX Corporation (IRIX)vs › | $11.94M | -19.53% | -16.13% | -40.26% | -33.39% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.34M | -74.94% | -273.26% | -277.38% | -186.51% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.42M | -240.64% | -174.03% | -198.05% | -242.53% |
| Biofrontera Inc. (BFRI)vs › | $11.41M | -32.27% | -112.80% | -113.13% | -94.20% |
| Vyome Holdings, Inc. (HIND)vs › | $13.55M | -57.53% | -660.45% | -553.22% | -396.73% |
| IN8bio, Inc. (INAB)vs › | $13.62M | -91.74% | -119.31% | -112.64% | -88.90% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.21M | -59.42% | -18.05% | -54.95% | -57.91% |
ROIC
-43.3%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -43.31% |
| 2026-03-31 | -42.57% |
| 2025-12-31 | -41.31% |
| 2025-09-30 | -40.43% |
| 2025-06-30 | -41.79% |
| 2025-03-31 | -38.73% |
| 2024-12-31 | -44.39% |
| 2024-09-30 | -56.55% |
| 2024-06-30 | -58.52% |
| 2024-03-31 | -78.04% |
| 2023-12-31 | -76.29% |
| 2023-09-30 | -77.28% |
| 2023-06-30 | -70.66% |
| 2023-03-31 | -67.08% |
| 2022-12-31 | -58.90% |
| 2022-09-30 | -66.59% |
| 2022-06-30 | -51.30% |
| 2022-03-31 | -40.35% |
| 2021-12-31 | -29.77% |
| 2021-09-30 | -18.83% |
| 2021-06-30 | -14.15% |
| 2021-03-31 | -13.82% |
| 2020-12-31 | -13.00% |
| 2020-09-30 | -13.70% |
| 2020-06-30 | -41.39% |
| 2020-03-31 | -46.49% |
| 2019-12-31 | -97.10% |
| 2019-09-30 | -84.99% |
| 2019-06-30 | -71.11% |
| 2019-03-31 | -64.62% |
| 2018-12-31 | -57.99% |
| 2018-09-30 | -46.03% |
| 2018-06-30 | -42.10% |
| 2018-03-31 | -46.82% |
| 2017-12-31 | -48.59% |
| 2017-09-30 | -54.56% |
| 2017-06-30 | -59.37% |
| 2017-03-31 | -326.50% |
| 2016-12-31 | -258.95% |
| 2016-09-30 | -152.73% |
| 2016-06-30 | -109.25% |
| 2016-03-31 | -145.76% |
| 2015-12-31 | -113.30% |
| 2015-09-30 | -103.63% |
| 2015-06-30 | -79.78% |
| 2015-03-31 | -86.77% |
| 2014-12-31 | -183.64% |
| 2014-09-30 | -64.71% |
| 2014-06-30 | -48.07% |
| 2014-03-31 | -41.08% |
| 2013-12-31 | -179.53% |
| 2013-09-30 | -178.39% |
| 2013-06-30 | -237.16% |
| 2013-03-31 | -250.84% |
| 2012-12-31 | -159.49% |
| 2012-09-30 | -92.59% |
| 2012-06-30 | -132.17% |
| 2012-03-31 | -143.01% |
| 2011-12-31 | -274.47% |
| 2011-09-30 | -134.35% |
| 2011-06-30 | -77.06% |
| 2011-03-31 | -99.77% |
| 2010-12-31 | -262.01% |
| 2010-03-31 | -534.97% |
| 2009-12-31 | -215.84% |
| 2009-09-30 | -907.69% |
| 2009-06-30 | -370.28% |
| 2009-03-31 | -101.52% |
| 2008-12-31 | -67.31% |
| 2008-09-30 | -44.43% |
| 2008-06-30 | -37.89% |
| 2007-09-30 | -742.75% |
| 2007-06-30 | -685.74% |
| 2007-03-31 | -251.01% |
| 2006-12-31 | -91.53% |
